2023 Q4 Form 10-Q Financial Statement

#000160064123000221 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $20.92M $20.66M
YoY Change -8.86% -9.09%
Cost Of Revenue $5.967M $5.510M
YoY Change -11.76% -24.29%
Gross Profit $14.96M $15.15M
YoY Change -7.66% -1.93%
Gross Profit Margin 71.48% 73.33%
Selling, General & Admin $15.69M $15.18M
YoY Change -17.86% -14.72%
% of Gross Profit 104.89% 100.2%
Research & Development $4.445M $4.515M
YoY Change -22.37% -29.04%
% of Gross Profit 29.72% 29.8%
Depreciation & Amortization $463.0K $400.0K
YoY Change -11.13% -42.86%
% of Gross Profit 3.1% 2.64%
Operating Expenses $20.13M $20.39M
YoY Change -18.9% -19.58%
Operating Profit -$5.176M -$5.233M
YoY Change -40.01% -47.13%
Interest Expense $1.706M $0.00
YoY Change 98.37% -100.0%
% of Operating Profit
Other Income/Expense, Net $543.0K $1.928M
YoY Change -42.48% 121.61%
Pretax Income -$2.927M -$3.305M
YoY Change -57.11% -63.39%
Income Tax $14.00K $0.00
% Of Pretax Income
Net Earnings -$2.941M -$3.305M
YoY Change -57.13% -63.39%
Net Earnings / Revenue -14.06% -15.99%
Basic Earnings Per Share -$0.08
Diluted Earnings Per Share -$0.07 -$0.08
COMMON SHARES
Basic Shares Outstanding 39.98M shares 38.78M shares
Diluted Shares Outstanding 39.96M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $139.3M $143.0M
YoY Change -9.06% -9.49%
Cash & Equivalents $37.40M $32.44M
Short-Term Investments $101.9M $110.6M
Other Short-Term Assets $2.214M $942.0K
YoY Change 176.75% -63.7%
Inventory
Prepaid Expenses $3.032M $2.612M
Receivables $600.0K $693.0K
Other Receivables $2.670M $3.475M
Total Short-Term Assets $147.9M $150.7M
YoY Change -8.98% -10.89%
LONG-TERM ASSETS
Property, Plant & Equipment $3.384M $3.283M
YoY Change -8.17% -18.39%
Goodwill $4.116M $4.082M
YoY Change 1.01% 1.72%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.200M $1.286M
YoY Change 794.31% -63.92%
Total Long-Term Assets $32.94M $32.06M
YoY Change -1.19% -6.38%
TOTAL ASSETS
Total Short-Term Assets $147.9M $150.7M
Total Long-Term Assets $32.94M $32.06M
Total Assets $180.8M $182.8M
YoY Change -7.65% -10.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.580M $2.325M
YoY Change 23.24% -8.64%
Accrued Expenses $10.88M $11.32M
YoY Change 1.13% -9.44%
Deferred Revenue $100.0K
YoY Change 0.0%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $27.71M $26.96M
YoY Change 6.37% -10.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.000K $8.000K
YoY Change -86.96% -88.41%
Total Long-Term Liabilities $6.000K $8.000K
YoY Change -86.96% -88.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.71M $26.96M
Total Long-Term Liabilities $6.000K $8.000K
Total Liabilities $46.53M $46.46M
YoY Change -2.61% -11.8%
SHAREHOLDERS EQUITY
Retained Earnings -$313.7M -$310.8M
YoY Change 7.8% 9.37%
Common Stock $407.0K $403.0K
YoY Change 3.56% 4.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $134.3M $136.3M
YoY Change
Total Liabilities & Shareholders Equity $180.8M $182.8M
YoY Change -7.65% -10.13%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$2.941M -$3.305M
YoY Change -57.13% -63.39%
Depreciation, Depletion And Amortization $463.0K $400.0K
YoY Change -11.13% -42.86%
Cash From Operating Activities -$2.081M -$2.210M
YoY Change -62.19% -45.7%
INVESTING ACTIVITIES
Capital Expenditures $512.0K $400.0K
YoY Change 166.67% -171.43%
Acquisitions
YoY Change
Other Investing Activities $9.880M -$8.910M
YoY Change 82233.33% 890900.0%
Cash From Investing Activities $9.368M -$9.310M
YoY Change -5304.44% 1559.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.395M -1.270M
YoY Change -591.79% -511.0%
NET CHANGE
Cash From Operating Activities -2.081M -2.210M
Cash From Investing Activities 9.368M -9.310M
Cash From Financing Activities -2.395M -1.270M
Net Change In Cash 4.892M -12.79M
YoY Change -194.13% 195.93%
FREE CASH FLOW
Cash From Operating Activities -$2.081M -$2.210M
Capital Expenditures $512.0K $400.0K
Free Cash Flow -$2.593M -$2.610M
YoY Change -54.48% -25.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1500000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
195000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
113000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
693000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
972000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2612000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3506000 usd
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3475000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2476000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
942000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
150716000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
162463000 usd
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3336000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3334000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3283000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3685000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20073000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21990000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
4082000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
4075000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1286000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
249000 usd
CY2023Q3 us-gaap Assets
Assets
182776000 usd
CY2022Q4 us-gaap Assets
Assets
195796000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2325000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2905000 usd
CY2023Q3 dibs Payables To Sellers Current
PayablesToSellersCurrent
7789000 usd
CY2022Q4 dibs Payables To Sellers Current
PayablesToSellersCurrent
7185000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
47774000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40386375 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39260193 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
403000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
800000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11323000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10761000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2891000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2770000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2633000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2429000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
26961000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26050000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19494000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21678000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
46000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
46463000 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39260193 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40051416 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
393000 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
334959 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1377000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
448544000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
439005000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-310778000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-291020000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-479000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-356000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
136313000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
148022000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
182776000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
195796000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
63762000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73892000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19144000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22908000 usd
us-gaap Gross Profit
GrossProfit
44618000 usd
us-gaap Gross Profit
GrossProfit
50984000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28007000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
34139000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17199000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18711000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22323000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20635000 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
688000 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1183000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2940000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4432000 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
20386000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
25349000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5233000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
746000 usd
us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
11000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
353000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1160000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
837000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1928000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
870000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6093000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1572000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3305000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9028000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19758000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15677000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3305000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9028000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19758000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15677000 usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39962932 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39962932 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38668231 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38668231 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39647716 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39647716 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38291977 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38291977 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9028000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19758000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15677000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 usd
us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 usd
us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-34000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-103000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
9000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-272000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-12000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-132000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3351000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9131000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19881000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15949000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
137974000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
43000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3024000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1377000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-46000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3305000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
136313000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
148022000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
78000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9471000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1377000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-123000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19758000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
136313000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
156367000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
309000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3154000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-103000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9028000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
150699000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7662000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-272000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15677000 usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
9684000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2366000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-517000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
999000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1215000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
602000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-210000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3692000 usd
dibs Increase Decrease In Payables To Sellers
IncreaseDecreaseInPayablesToSellers
606000 usd
dibs Increase Decrease In Payables To Sellers
IncreaseDecreaseInPayablesToSellers
-977000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2063000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2036000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
103000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-293000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11475000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22410000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
166471000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
58153000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 usd
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 usd
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
14611000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
18000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-109600000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12821000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
78000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1548000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1312000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
10000 usd
us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.20
us-gaap Restructuring Charges
RestructuringCharges
2000000 usd
CY2023Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
1400000 usd
CY2023Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
600000 usd
us-gaap Depreciation
Depreciation
1800000 usd
CY2023Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
400000 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1700000 usd
dibs Capitalized Computer Software Accelerated Amortization
CapitalizedComputerSoftwareAcceleratedAmortization
500000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
700000 usd
us-gaap Depreciation
Depreciation
2100000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
us-gaap Restructuring Charges
RestructuringCharges
2004000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
1374000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
630000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Use Of Estimates
UseOfEstimates
The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these condensed consolidated financial statements include, but are not limited to, revenue recognition, provision for transaction losses, determination of useful lives of property and equipment, impairment assessment of goodwill, capitalization of internal-use software and determination of useful lives, income taxes, and the valuation of stock-based compensation and leases. The Company evaluates its estimates and assumptions on an ongoing basis. Actual results could differ from those estimates and such differences may be material to the condensed consolidated financial statements.
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32442000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
157995000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1500000 usd
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3336000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3334000 usd
CY2022Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
700000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
0 usd
CY2023Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
20000000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
7870000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
110552000 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
2000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20663000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22729000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
63762000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73892000 usd
CY2023Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
500000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
500000 usd
CY2023Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
300000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
300000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
200000 usd
CY2023Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
200000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
100000 usd
CY2023Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
100000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
200000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
200000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.059
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22000000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2800000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21700000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1000000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
110684000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
10000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
142000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
110552000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
99000000 usd
CY2023Q3 dibs Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOne
11552000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
110552000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25201000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24539000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21918000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20854000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3283000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3685000 usd
CY2023Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
2600000 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3000000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
400000 usd
CY2023Q3 dibs Accrued Shipping Costs Current
AccruedShippingCostsCurrent
3213000 usd
CY2022Q4 dibs Accrued Shipping Costs Current
AccruedShippingCostsCurrent
3597000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3267000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1862000 usd
CY2023Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1159000 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1378000 usd
CY2023Q3 dibs Accounts Receivable Allowance For Transaction Loss Current
AccountsReceivableAllowanceForTransactionLossCurrent
1200000 usd
CY2022Q4 dibs Accounts Receivable Allowance For Transaction Loss Current
AccountsReceivableAllowanceForTransactionLossCurrent
1327000 usd
CY2023Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
630000 usd
CY2022Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
0 usd
CY2023Q3 dibs Accrued Payment Processor Fees Current
AccruedPaymentProcessorFeesCurrent
525000 usd
CY2022Q4 dibs Accrued Payment Processor Fees Current
AccruedPaymentProcessorFeesCurrent
970000 usd
CY2023Q3 dibs Accounts Receivable Allowance For Returns Current
AccountsReceivableAllowanceForReturnsCurrent
392000 usd
CY2022Q4 dibs Accounts Receivable Allowance For Returns Current
AccountsReceivableAllowanceForReturnsCurrent
438000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
937000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1189000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11323000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10761000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20100000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2900000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19500000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
3100000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1100000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
3200000 usd
CY2023Q3 dibs Sublease Abatement Provision Term
SubleaseAbatementProvisionTerm
P5M
CY2023Q3 us-gaap Payments For Brokerage Fees
PaymentsForBrokerageFees
1100000 usd
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
991000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1000000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
2979000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
2987000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
33000 usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
22000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
87000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
196000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
287000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
772000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
776000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
1220000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
1309000 usd
us-gaap Lease Cost
LeaseCost
3838000 usd
us-gaap Lease Cost
LeaseCost
3863000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1020000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4114000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4292000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4292000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4292000 usd
CY2023Q3 dibs Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
8583000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
26593000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4208000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
22385000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
577398 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
7.00
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
4116974 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.49
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.11
CY2023Q3 dibs Sales And Excise Tax Contingencies Payable Current
SalesAndExciseTaxContingenciesPayableCurrent
1946000 usd
CY2022Q4 dibs Sales And Excise Tax Contingencies Payable Current
SalesAndExciseTaxContingenciesPayableCurrent
1863000 usd
CY2023Q3 dibs Contract With Customer Buyer Deposits Liability Current
ContractWithCustomerBuyerDepositsLiabilityCurrent
392000 usd
CY2022Q4 dibs Contract With Customer Buyer Deposits Liability Current
ContractWithCustomerBuyerDepositsLiabilityCurrent
318000 usd
CY2023Q3 dibs Contract With Customer Deferred Revenue Liability Current
ContractWithCustomerDeferredRevenueLiabilityCurrent
99000 usd
CY2022Q4 dibs Contract With Customer Deferred Revenue Liability Current
ContractWithCustomerDeferredRevenueLiabilityCurrent
140000 usd
CY2023Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
196000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
108000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2633000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2429000 usd
CY2023Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12401640 shares
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11173994 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
334959 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1400000 usd
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1400000 usd
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
18600000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.95
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4034287 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.90
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1625000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
19978 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.90
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
83973 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
6.38
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3930336 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.92
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2799980 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.27
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y4M24D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3930336 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
6.92
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y1M6D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1100000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.43
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.43
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
700000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2700000 usd
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
800000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3400000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2807981 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
7.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2992595 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.95
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1106204 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
6.54
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.23
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.61
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
2000000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
7200000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
2100000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
4300000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2982000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3154000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9340000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7662000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
100000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
100000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
100000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
100000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
27000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3305000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9028000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19758000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15677000 usd
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39962932 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39962932 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38668231 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38668231 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39647716 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39647716 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38291977 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38291977 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8047310 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7156979 shares
CY2023Q3 us-gaap Contractual Obligation
ContractualObligation
28800000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1020000 usd
CY2023Q3 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
372000 usd
CY2023Q3 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
1392000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4114000 usd
CY2023Q3 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
1291000 usd
CY2023Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
5405000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4292000 usd
CY2023Q3 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
506000 usd
CY2023Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
4798000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4292000 usd
CY2023Q3 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
33000 usd
CY2023Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
4325000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4292000 usd
CY2023Q3 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
0 usd
CY2023Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
4292000 usd
CY2023Q3 dibs Lessee Operating Lease Liability To Be Paid Thereafter
LesseeOperatingLeaseLiabilityToBePaidThereafter
8583000 usd
CY2023Q3 dibs Purchase Obligation To Be Paid Thereafter
PurchaseObligationToBePaidThereafter
0 usd
CY2023Q3 dibs Contractual Obligation To Be Paid Thereafter
ContractualObligationToBePaidThereafter
8583000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
26593000 usd
CY2023Q3 us-gaap Purchase Obligation
PurchaseObligation
2202000 usd
CY2023Q3 us-gaap Contractual Obligation
ContractualObligation
28795000 usd

Files In Submission

Name View Source Status
dibs-20230930_pre.xml Edgar Link unprocessable
0001600641-23-000221-index-headers.html Edgar Link pending
0001600641-23-000221-index.html Edgar Link pending
0001600641-23-000221.txt Edgar Link pending
0001600641-23-000221-xbrl.zip Edgar Link pending
dibs-20230930.htm Edgar Link pending
dibs-20230930.xsd Edgar Link pending
ex101executedleaseagreem.htm Edgar Link pending
ex101executedleaseagreem001.jpg Edgar Link pending
ex101executedleaseagreem002.jpg Edgar Link pending
ex101executedleaseagreem003.jpg Edgar Link pending
ex101executedleaseagreem004.jpg Edgar Link pending
ex101executedleaseagreem005.jpg Edgar Link pending
ex101executedleaseagreem006.jpg Edgar Link pending
ex101executedleaseagreem007.jpg Edgar Link pending
ex101executedleaseagreem008.jpg Edgar Link pending
ex101executedleaseagreem009.jpg Edgar Link pending
ex101executedleaseagreem010.jpg Edgar Link pending
ex101executedleaseagreem011.jpg Edgar Link pending
ex101executedleaseagreem012.jpg Edgar Link pending
ex101executedleaseagreem013.jpg Edgar Link pending
ex101executedleaseagreem014.jpg Edgar Link pending
ex101executedleaseagreem015.jpg Edgar Link pending
ex101executedleaseagreem016.jpg Edgar Link pending
ex101executedleaseagreem017.jpg Edgar Link pending
ex101executedleaseagreem018.jpg Edgar Link pending
ex101executedleaseagreem019.jpg Edgar Link pending
ex101executedleaseagreem020.jpg Edgar Link pending
ex101executedleaseagreem021.jpg Edgar Link pending
ex101executedleaseagreem022.jpg Edgar Link pending
ex101executedleaseagreem023.jpg Edgar Link pending
ex101executedleaseagreem024.jpg Edgar Link pending
ex101executedleaseagreem025.jpg Edgar Link pending
ex101executedleaseagreem026.jpg Edgar Link pending
ex101executedleaseagreem027.jpg Edgar Link pending
ex101executedleaseagreem028.jpg Edgar Link pending
ex101executedleaseagreem029.jpg Edgar Link pending
ex101executedleaseagreem030.jpg Edgar Link pending
ex101executedleaseagreem031.jpg Edgar Link pending
dibs-20230930_htm.xml Edgar Link completed
ex101executedleaseagreem032.jpg Edgar Link pending
ex101executedleaseagreem033.jpg Edgar Link pending
ex101executedleaseagreem034.jpg Edgar Link pending
ex101executedleaseagreem035.jpg Edgar Link pending
ex101executedleaseagreem036.jpg Edgar Link pending
ex101executedleaseagreem037.jpg Edgar Link pending
ex101executedleaseagreem038.jpg Edgar Link pending
ex101executedleaseagreem039.jpg Edgar Link pending
ex101executedleaseagreem040.jpg Edgar Link pending
ex101executedleaseagreem041.jpg Edgar Link pending
ex101executedleaseagreem042.jpg Edgar Link pending
ex101executedleaseagreem043.jpg Edgar Link pending
ex101executedleaseagreem044.jpg Edgar Link pending
ex101executedleaseagreem045.jpg Edgar Link pending
ex101executedleaseagreem046.jpg Edgar Link pending
ex101executedleaseagreem047.jpg Edgar Link pending
ex101executedleaseagreem048.jpg Edgar Link pending
ex101executedleaseagreem049.jpg Edgar Link pending
ex101executedleaseagreem050.jpg Edgar Link pending
ex101executedleaseagreem051.jpg Edgar Link pending
ex101executedleaseagreem052.jpg Edgar Link pending
ex101executedleaseagreem053.jpg Edgar Link pending
ex101executedleaseagreem054.jpg Edgar Link pending
ex101executedleaseagreem055.jpg Edgar Link pending
ex101executedleaseagreem056.jpg Edgar Link pending
ex101executedleaseagreem057.jpg Edgar Link pending
ex101executedleaseagreem058.jpg Edgar Link pending
ex101executedleaseagreem059.jpg Edgar Link pending
ex101executedleaseagreem060.jpg Edgar Link pending
ex101executedleaseagreem061.jpg Edgar Link pending
ex101executedleaseagreem062.jpg Edgar Link pending
ex101executedleaseagreem063.jpg Edgar Link pending
ex101executedleaseagreem064.jpg Edgar Link pending
ex101executedleaseagreem065.jpg Edgar Link pending
ex101executedleaseagreem066.jpg Edgar Link pending
ex101executedleaseagreem067.jpg Edgar Link pending
ex101executedleaseagreem068.jpg Edgar Link pending
ex101executedleaseagreem069.jpg Edgar Link pending
ex101executedleaseagreem070.jpg Edgar Link pending
ex101executedleaseagreem071.jpg Edgar Link pending
ex101executedleaseagreem072.jpg Edgar Link pending
ex101executedleaseagreem073.jpg Edgar Link pending
ex101executedleaseagreem074.jpg Edgar Link pending
ex101executedleaseagreem075.jpg Edgar Link pending
ex101executedleaseagreem076.jpg Edgar Link pending
ex101executedleaseagreem077.jpg Edgar Link pending
ex101executedleaseagreem078.jpg Edgar Link pending
ex101executedleaseagreem079.jpg Edgar Link pending
ex101executedleaseagreem080.jpg Edgar Link pending
ex101executedleaseagreem081.jpg Edgar Link pending
ex101executedleaseagreem082.jpg Edgar Link pending
ex101executedleaseagreem083.jpg Edgar Link pending
ex101executedleaseagreem084.jpg Edgar Link pending
ex101executedleaseagreem085.jpg Edgar Link pending
ex101executedleaseagreem086.jpg Edgar Link pending
ex101executedleaseagreem087.jpg Edgar Link pending
ex101executedleaseagreem088.jpg Edgar Link pending
ex101executedleaseagreem089.jpg Edgar Link pending
ex101executedleaseagreem090.jpg Edgar Link pending
ex101executedleaseagreem091.jpg Edgar Link pending
ex101executedleaseagreem092.jpg Edgar Link pending
ex101executedleaseagreem093.jpg Edgar Link pending
ex101executedleaseagreem094.jpg Edgar Link pending
ex101executedleaseagreem095.jpg Edgar Link pending
ex101executedleaseagreem096.jpg Edgar Link pending
ex101executedleaseagreem097.jpg Edgar Link pending
ex101executedleaseagreem098.jpg Edgar Link pending
ex101executedleaseagreem099.jpg Edgar Link pending
ex101executedleaseagreem100.jpg Edgar Link pending
ex101executedleaseagreem101.jpg Edgar Link pending
ex101executedleaseagreem102.jpg Edgar Link pending
ex101executedleaseagreem103.jpg Edgar Link pending
ex101executedleaseagreem104.jpg Edgar Link pending
ex101executedleaseagreem105.jpg Edgar Link pending
ex101executedleaseagreem106.jpg Edgar Link pending
ex101executedleaseagreem107.jpg Edgar Link pending
ex101executedleaseagreem108.jpg Edgar Link pending
ex101executedleaseagreem109.jpg Edgar Link pending
ex26dailyrepurchasedata.htm Edgar Link pending
ex311q3fy23ceocert.htm Edgar Link pending
ex312q3fy23cfocert.htm Edgar Link pending
ex321q3fy23ceocert.htm Edgar Link pending
ex322q3fy23cfocert.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dibs-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dibs-20230930_def.xml Edgar Link unprocessable
dibs-20230930_cal.xml Edgar Link unprocessable